HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylvie Brassart-Pasco Selected Research

Fibril-Associated Collagens (FACIT Collagen)

1/2016The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylvie Brassart-Pasco Research Topics

Disease

24Neoplasms (Cancer)
12/2021 - 12/2006
12Melanoma (Melanoma, Malignant)
12/2021 - 12/2006
2Hypoxia (Hypoxemia)
01/2020 - 01/2020
2Rhabdomyosarcoma
01/2017 - 01/2016
2Fibrosarcoma
05/2016 - 01/2015
1Carcinoma (Carcinomatosis)
12/2020
1Acidosis
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Inflammation (Inflammations)
01/2019
1Carcinogenesis
01/2019
1Breast Neoplasms (Breast Cancer)
01/2018
1Choristoma (Ectopic Tissue)
01/2015
1Neoplasm Metastasis (Metastasis)
01/2012

Drug/Important Bio-Agent (IBA)

13CollagenIBA
12/2021 - 02/2007
11Peptides (Polypeptides)IBA
12/2021 - 12/2006
5Peptide Hydrolases (Proteases)FDA Link
01/2020 - 01/2012
4Antineoplastic Agents (Antineoplastics)IBA
12/2021 - 03/2010
4type IV collagen alpha3 chain (Goodpasture antigen)IBA
08/2014 - 03/2010
3IntegrinsIBA
12/2021 - 01/2016
3ElastinIBA
12/2020 - 04/2018
3YSNSG cyclopeptideIBA
02/2020 - 12/2006
3Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2020
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
12/2020 - 01/2018
2EnzymesIBA
01/2020 - 02/2015
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2020
2Pharmaceutical PreparationsIBA
01/2020 - 01/2015
2Collagen Type I (Type I Collagen)IBA
01/2018 - 05/2016
2Recombinant ProteinsIBA
08/2014 - 01/2012
1TicagrelorIBA
01/2020
1Adenosine (Adenocard)FDA LinkGeneric
01/2020
1Free RadicalsIBA
01/2020
1Ion Channels (Ion Channel)IBA
01/2020
1LipidsIBA
01/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2020
1Nucleic AcidsIBA
01/2020
1Oxygen (Dioxygen)IBA
01/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2020
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2020
1ProteomeIBA
01/2020
1Collagen Type IV (Type IV Collagen)IBA
01/2020
1Caspase 3 (Caspase-3)IBA
01/2020
1Phenobarbital (Luminal)FDA Link
01/2018
1Discoidin Domain ReceptorsIBA
05/2016
1Biological ProductsIBA
05/2016
1Fibril-Associated Collagens (FACIT Collagen)IBA
01/2016
1FibrinolysinFDA Link
02/2015
1DecitabineFDA Link
01/2015
1Matrix Metalloproteinases (MMPs)IBA
01/2015
1DNA (Deoxyribonucleic Acid)IBA
01/2015
1Angiogenesis InhibitorsIBA
08/2014
1N-acetylsphingosineIBA
10/2008
1Histones (Histone)IBA
10/2008
1trichostatin A (A 300)IBA
10/2008
1Histone Deacetylase InhibitorsIBA
10/2008
1CeramidesIBA
10/2008
1matrigelIBA
02/2007

Therapy/Procedure

2Therapeutics
04/2018 - 08/2014
2Drug Therapy (Chemotherapy)
08/2014 - 01/2012
2Radiotherapy
08/2014 - 01/2012
1Immunotherapy
01/2020
1Subcutaneous Injections
01/2012